Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,627 | 57,165 | 18,842 | 22,450 | 7,092 |
| TOTAL | $54,402 | $57,940 | $19,803 | $23,044 | $7,863 |
| Non-Current Assets | |||||
| PPE Net | 318 | 356 | 375 | 411 | 412 |
| Other Non-Current Assets | 345 | 364 | 519 | 398 | 414 |
| TOTAL | $663 | $720 | $894 | $809 | $826 |
| Total Assets | $55,065 | $58,659 | $20,697 | $23,853 | $8,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,896 | 3,443 | 3,839 | 3,207 | 2,941 |
| TOTAL | $5,020 | $3,563 | $3,956 | $3,320 | $3,051 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 184 | 184 | N/A |
| Other Non-Current Liabilities | 269 | 302 | 333 | 364 | 393 |
| TOTAL | $269 | $302 | $517 | $548 | $393 |
| Total Liabilities | $5,289 | $3,865 | $4,473 | $3,867 | $3,444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 176 | 168 | 89 | 89 | 31 |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -133,133 | -126,775 | -123,160 | -119,251 | -115,639 |
| Other shareholders' equity | 11,747 | 18,888 | 0 | 0 | 0 |
| TOTAL | $49,776 | $54,795 | $16,224 | $19,985 | $5,246 |
| Total Liabilities And Equity | $55,065 | $58,659 | $20,697 | $23,853 | $8,690 |